nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adoptive cell therapies in thoracic malignancies
|
Lasvergnas, Julie |
|
|
71 |
9 |
p. 2077-2098 |
artikel |
2 |
Antibody-dependent cellular phagocytosis of tropomyosin receptor kinase C (TrkC) expressing cancer cells for targeted immunotherapy
|
Lai, Phei San |
|
|
71 |
9 |
p. 2099-2108 |
artikel |
3 |
Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18
|
Aarsund, Miriam |
|
|
71 |
9 |
p. 2227-2238 |
artikel |
4 |
Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
|
von Itzstein, Mitchell S. |
|
|
71 |
9 |
p. 2183-2184 |
artikel |
5 |
Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
|
von Itzstein, Mitchell S. |
|
|
71 |
9 |
p. 2169-2181 |
artikel |
6 |
Enhancing the anti-leukemia immunity of acute lymphocytic leukemia-derived exosome-based vaccine by downregulation of PD-L1 expression
|
Huang, Fang |
|
|
71 |
9 |
p. 2197-2212 |
artikel |
7 |
GM-CSF elicits antibodies to tumor-associated proteins when used as a prostate cancer vaccine adjuvant
|
Potluri, Hemanth K. |
|
|
71 |
9 |
p. 2267-2275 |
artikel |
8 |
Immune escape mechanism behind resistance to anti-PD-1 therapy in gastrointestinal tract metastasis in malignant melanoma patients with multiple metastases
|
Ito, Misato |
|
|
71 |
9 |
p. 2293-2300 |
artikel |
9 |
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer
|
Yu, Yanze |
|
|
71 |
9 |
p. 2117-2126 |
artikel |
10 |
Inflammasome activation, NLRP3 engagement and macrophage recruitment to tumor microenvironment are all required for Salmonella antitumor effect
|
Mónaco, Amy |
|
|
71 |
9 |
p. 2141-2150 |
artikel |
11 |
Interleukin-12 as an in situ cancer vaccine component: a review
|
Cheng, Emily M. |
|
|
71 |
9 |
p. 2057-2065 |
artikel |
12 |
Murine myeloid derived suppressor cells possess a range of suppressive mechanisms—Granzyme B is not among them
|
Tibbs, Ellis |
|
|
71 |
9 |
p. 2255-2266 |
artikel |
13 |
Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration
|
Kawaguchi, Sho |
|
|
71 |
9 |
p. 2127-2139 |
artikel |
14 |
Pancreatic cancer survival prediction via inflammatory serum markers
|
Lanki, Mira |
|
|
71 |
9 |
p. 2287-2292 |
artikel |
15 |
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression
|
Filippone, A. |
|
|
71 |
9 |
p. 2067-2075 |
artikel |
16 |
Phase I study of expanded natural killer cells in combination with cetuximab for recurrent/metastatic nasopharyngeal carcinoma
|
Lim, Chwee Ming |
|
|
71 |
9 |
p. 2277-2286 |
artikel |
17 |
Pre-treatment serum protein levels predict survival of non-small cell lung cancer patients without durable clinical benefit by PD-1/L1 inhibitors
|
Harutani, Yuhei |
|
|
71 |
9 |
p. 2109-2116 |
artikel |
18 |
Severe immune-related adverse events of immune checkpoint inhibitors for advanced non-small cell lung cancer: a network meta-analysis of randomized clinical trials
|
Gu, Jingjing |
|
|
71 |
9 |
p. 2239-2254 |
artikel |
19 |
Single-cell transcriptome profiling reveals intra-tumoral heterogeneity in human chordomas
|
Duan, Wanru |
|
|
71 |
9 |
p. 2185-2195 |
artikel |
20 |
Targeting transforming growth factor-β2 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancer
|
Lee, Hong Kyu |
|
|
71 |
9 |
p. 2213-2226 |
artikel |
21 |
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC
|
Guti, Eliza |
|
|
71 |
9 |
p. 2151-2168 |
artikel |